Endoluminal Therapy for Barrett's Esophagus

Gastrointestinal Endoscopy Clinics of North America

Volumn 17, Issue 1, 2007, Pages 59-82

  Wolfsen, Herbert C ^a,b  

^a Mayo Clinic   (United States)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLOPIDOGREL; PHOTOFRIN; WARFARIN;

ARGON PLASMA COAGULATION; BARRETT ESOPHAGUS; BLEEDING; CONSTIPATION; DEHYDRATION; DRUG WITHDRAWAL; DYSPHAGIA; DYSPLASIA; ELECTROCOAGULATION; ENDOSCOPIC MUCOSAL RESECTION; ENDOSCOPIC SURGERY; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGUS RESECTION; ESOPHAGUS STRICTURE; FEVER; HICCUP; HUMAN; LOW LEVEL LASER THERAPY; NAUSEA AND VOMITING; PHOTODYNAMIC THERAPY; PHOTOTOXICITY; PLEURA EFFUSION; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; REVIEW; RISK ASSESSMENT; THORAX PAIN;

BARRETT ESOPHAGUS; ENDOSCOPY, GASTROINTESTINAL; HUMANS; INTESTINAL MUCOSA; TREATMENT OUTCOME;

EID: 33947596622     PISSN: 10525157     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.giec.2006.12.003     Document Type: Review

References (149)

1. Barrett N.R. The lower esophagus lined by columnar epithelium. Surgery 41 6 (1957) 881-894
2. Allison P.R. Peptic ulcer of the esophagus. J Thorac Surg 15 (1946) 308-317
3. Allison P.R. Peptic ulcer of the esophagus. Thorax 3 (1948) 20-42
4. Allison P.R., and Johnstone A.S. The oesophagus lined with gastric mucous membrane. Thorax 8 2 (1953) 87-101
5. Allison P.R., Johnstone A.S., and Royce G.B. Short esophagus with simple peptic ulceration. J Thorac Surg 12 (1943) 432-457
6. Iascone C., DeMeester T.R., Little A.G., et al. Barrett's esophagus. Functional assessment, proposed pathogenesis, and surgical therapy. Arch Surg 118 5 (1983) 543-549
7. Blot W.J., Devesa S.S., Kneller R.W., et al. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA 265 10 (1991) 1287-1289
8. Triadafilopoulos G., Kaur B., Sood S., et al. The effects of esomeprazole combined with aspirin or rofecoxib, on prostaglandin E2 production in patients with Barrett's oesophagus. Aliment Pharmacol Ther 23 7 (2006) 997-1005
9. Wild C.P., and Hardie L.J. Reflux, Barrett's oesophagus and adenocarcinoma: burning questions. Nat Rev Cancer 3 9 (2003) 676-684
10. Vaughan T.L., Dong L.M., Blount P.L., et al. Nonsteroidal anti-inflammatory drugs and risk of neoplastic progression in Barrett's oesophagus: a prospective study. Lancet Oncol 6 12 (2005) 945-952
11. Eisen G.M. Ablation therapy for Barrett's esophagus. Gastrointest Endosc 58 5 (2003) 760-769
12. Drewitz D.J., Sampliner R.E., and Garewal H.S. The incidence of adenocarcinoma in Barrett's esophagus: a prospective study of 170 patients followed 4.8 years. Am J Gastroenterol 92 2 (1997) 212-215
13. O'Connor J.B., Falk G.W., and Richter J.E. The incidence of adenocarcinoma and dysplasia in Barrett's esophagus: report on the Cleveland Clinic Barrett's esophagus registry. Am J Gastroenterol 94 8 (1999) 2037-2042
14. Sharma D., Reker D., Falk G., et al. Progression of Barrett's esophagus to high-grade dysplasia and cancer: preliminary results of the BEST trial. Gastroenterology 120 (2001) A16
15. Provenzale D., Kemp J.A., Arora S., et al. A guide for surveillance of patients with Barrett's esophagus. Am J Gastroenterol 89 5 (1994) 670-680
16. Reid B.J. Barrett's esophagus and esophageal adenocarcinoma. Gastroenterol Clin North Am 20 4 (1991) 817-834
17. American Cancer Society. Cancer facts and figures 2005 (2005), American Cancer Society, Atlanta (GA)
18. Shaheen N., and Ransohoff D.F. Gastroesophageal reflux, Barrett's esophagus, and esophageal cancer: scientific review. JAMA 287 15 (2002) 1972-1981
19. Sharma P., Falk G.W., Weston A.P., et al. Dysplasia and cancer in a large multicenter cohort of patients with Barrett's esophagus. Clin Gastroenterol Hepatol 4 5 (2006) 566-572
20. Sharma P., McQuaid K., Dent J., et al. A critical review of the diagnosis and management of Barrett's esophagus: the AGA Chicago workshop. Gastroenterology 127 1 (2004) 310-330
21. Bartels H., Stein H.J., and Siewert J.R. Risk analysis in esophageal surgery. Recent Results Cancer Res 155 (2000) 89-96
22. Urbach D.R., and Baxter N.N. Does it matter what a hospital is high-volume for? Specificity of hospital volume-outcome associations for surgical procedures: analysis of administrative data. BMJ 328 7442 (2004) 737-740
23. Dimick J.B., Wainess R.M., Upchurch Jr. G.R., et al. National trends in outcomes for esophageal resection. Ann Thorac Surg 79 1 (2005) 212-216
24. Lerut T.E., and van Lanschot J.J. Chronic symptoms after subtotal or partial oesophagectomy: diagnosis and treatment. Best Pract Res Clin Gastroenterol 18 5 (2004) 901-915
25. Puli S.R., Rostogi A., Mathur S., et al. Development of esophageal adenocarcinoma in patients with Barrett's esophagus and high-grade dysplasia undergoing surveillance: a meta-analysis and systematic review. Gastrointest Endosc 63 5 (2006) AB82
26. Spechler S.J. Thermal ablation of Barrett's esophagus: a heated debate. Am J Gastroenterol 101 8 (2006) 1770-1772
27. Wang K.K., and Sampliner R.E. Mucosal ablation therapy of Barrett's esophagus. Mayo Clin Proc 76 4 (2001) 433-437
28. Moghissi K., and Dixon K. Photodynamic therapy (PDT) in esophageal cancer: a surgical view of its indications based on 14 years experience. Technol Cancer Res Treat 2 4 (2003) 319-326
29. Wolfsen H.C. Endoprevention of esophageal cancer: endoscopic ablation of Barrett's metaplasia and dysplasia. Expert Rev Med Devices 2 6 (2005) 713-723
30. Alderson D. Observer variation in the diagnosis of superficial oesophageal adenocarcinoma: another spanner in the works?. Gut 51 5 (2002) 620-621
31. Ormsby A.H., Petras R.E., Henricks W.H., et al. Observer variation in the diagnosis of superficial oesophageal adenocarcinoma. Gut 51 5 (2002) 671-676
32. Zaninotto G., Parenti A.R., Ruol A., et al. Oesophageal resection for high-grade dysplasia in Barrett's oesophagus. Br J Surg 87 8 (2000) 1102-1105
33. Falk G.W., Rice T.W., Goldblum J.R., et al. Jumbo biopsy forceps protocol still misses unsuspected cancer in Barrett's esophagus with high-grade dysplasia. Gastrointest Endosc 49 2 (1999) 170-176
34. Montgomery E., Bronner M.P., Goldblum J.R., et al. Reproducibility of the diagnosis of dysplasia in Barrett's esophagus: a reaffirmation. Hum Pathol 32 4 (2001) 368-378
35. Das A., Chak A., Sivak Jr. M.V., et al. Endoscopic ultrasonography and prognosis of esophageal cancer. Clin Gastroenterol Hepatol 4 6 (2006) 695-700
36. Holscher A.H., Bollschweiler E., Schneider P.M., et al. Early adenocarcinoma in Barrett's oesophagus. Br J Surg 84 10 (1997) 1470-1473
37. Waxman I., Raju G.S., Critchlow J., et al. High-frequency probe ultrasonography has limited accuracy for detecting invasive adenocarcinoma in patients with Barrett's esophagus and high-grade dysplasia or intramucosal carcinoma: a case series. Am J Gastroenterol 101 (2006) 1773-1779
38. Chak A., Canto M.I., Isenberg G.A., et al. EUS assessment of response to chemoradiation in esophageal cancer patients. Am J Gastroenterol 100 2 (2005) 496-497
39. Rice T.W., Blackstone E.H., Adelstein D.J., et al. Role of clinically determined depth of tumor invasion in the treatment of esophageal carcinoma. J Thorac Cardiovasc Surg 125 5 (2003) 1091-1102
40. Rice T.W., Blackstone E.H., Adelstein D.J., et al. N1 esophageal carcinoma: the importance of staging and downstaging. J Thorac Cardiovasc Surg 121 3 (2001) 454-464
41. Wang K.K. Detection and staging of esophageal cancers. Curr Opin Gastroenterol 20 4 (2004) 381-385
42. Bergman J.J. New developments in the endoscopic detection and treatment of early neoplasia in Barrett's oesophagus. Scand J Gastroenterol Suppl 243 (2006) 18-24
43. Kara M.A., Peters F.P., Rosmolen W.D., et al. High-resolution endoscopy plus chromoendoscopy or narrow-band imaging in Barrett's esophagus: a prospective randomized crossover study. Endoscopy 37 10 (2005) 929-936
44. Coad R.A., Woodman A.C., Warner P.J., et al. On the histogenesis of Barrett's oesophagus and its associated squamous islands: a three-dimensional study of their morphological relationship with native oesophageal gland ducts. J Pathol 206 4 (2005) 388-394
45. Krishnadath K.K., Wang K.K., Taniguchi K., et al. Persistent genetic abnormalities in Barrett's esophagus after photodynamic therapy. Gastroenterology 119 3 (2000) 624-630
46. Basu K.K., Pick B., Bale R., et al. Efficacy and one-year follow-up of argon plasma coagulation therapy for ablation of Barrett's oesophagus: factors determining persistence and recurrence of Barrett's epithelium. Gut 51 6 (2002) 776-780
47. Wehrmann T., Frenz M.B., Stergiou N., et al. Frequency of recurrence of premalignant esophageal lesions and early stage esophageal cancer after endoscopic resection. Gastrointest Endosc 63 5 (2006) AB120
48. Wolfsen H.C., Hemminger L.L., Wallace M.B., et al. Clinical experience of patients undergoing photodynamic therapy for Barrett's dysplasia or cancer. Aliment Pharmacol Ther 20 10 (2004) 1125-1131
49. Sampliner R.E. Management of premalignant esophagogastric lesions. Ariz Med 39 5 (1982) 312-313
50. Sampliner R.E. Prevention of adenocarcinoma by reversing Barrett's esophagus with mucosal ablation. World J Surg 27 9 (2003) 1026-1029
51. Sampliner R.E. Epidemiology, pathophysiology, and treatment of Barrett's esophagus: reducing mortality from esophageal adenocarcinoma. Med Clin North Am 89 2 (2005) 293-312
52. Sampliner R.E., Hixson L.J., Fennerty M.B., et al. Regression of Barrett's esophagus by laser ablation in an acid environment. Dig Dis Sci 38 (1993) 365-368
53. Sampliner R.E., Fennerty B., and Garewal H.S. Reversal of Barrett's esophagus with acid suppression and multipolar electrocoagulation: preliminary results. Gastrointest Endosc 44 5 (1996) 532-535
54. Kovacs B.J., Chen Y.K., Lewis T.D., et al. Successful reversal of Barrett's esophagus with multipolar electrocoagulation despite inadequate acid suppression. Gastrointest Endosc 49 5 (1999) 547-553
55. Montes C.G., Brandalise N.A., Deliza R., et al. Antireflux surgery followed by bipolar electrocoagulation in the treatment of Barrett's esophagus. Gastrointest Endosc 50 2 (1999) 173-177
56. Sharma P., Sampliner R.E., and Camargo E. Normalization of esophageal pH with high-dose proton pump inhibitor therapy does not result in regression of Barrett's esophagus. Am J Gastroenterol 92 4 (1997) 582-585
57. Michopoulos S., Tsibouris P., Bouzakis H., et al. Complete regression of Barrett's esophagus with heat probe thermocoagulation: midterm results. Gastrointest Endosc 50 2 (1999) 165-172
58. Sampliner R.E., Faigel D., Fennerty M.B., et al. Effective and safe endoscopic reversal of nondysplastic Barrett's esophagus with thermal electrocoagulation combined with high-dose acid inhibition: a multicenter study. Gastrointest Endosc 53 6 (2001) 554-558
59. Grade A.J., Shah I.A., Medlin S.M., et al. The efficacy and safety of argon plasma coagulation therapy in Barrett's esophagus. Gastrointest Endosc 50 1 (1999) 18-22
60. Sampliner R.E. Endoscopic ablative therapy for Barrett's esophagus: current status. Gastrointest Endosc 59 1 (2004) 66-69
61. Kahaleh M., Van Laethem J.L., Nagy N., et al. Long-term follow-up and factors predictive of recurrence in Barrett's esophagus treated by argon plasma coagulation and acid suppression. Endoscopy 34 12 (2002) 950-955
62. Schulz H., Miehlke S., Antos D., et al. Ablation of Barrett's epithelium by endoscopic argon plasma coagulation in combination with high-dose omeprazole. Gastrointest Endosc 51 6 (2000) 659-663
63. Byrne J.P., Armstrong G.R., and Attwood S.E. Restoration of the normal squamous lining in Barrett's esophagus by argon beam plasma coagulation. Am J Gastroenterol 93 10 (1998) 1810-1815
64. Attwood S.E.A., Lewis C.J., Caplin S., et al. Argon beam plasma coagulation as therapy for high-grade dysplasia in Barrett's esophagus. Clinical Gastroenterology and Hepatology 1 4 (2003) 258-263
65. Ginsberg G.G., Barkun A.N., Bosco J.J., et al. The argon plasma coagulator. Gastrointest Endosc 55 7 (2002) 807-810
66. Pedrazzani C., Catalano F., Festini M., et al. Endoscopic ablation of Barrett's esophagus using high-power setting argon plasma coagulation: a prospective study. World J Gastroenterol 11 12 (2005) 1872-1875
67. Pinotti A.C., Cecconello I., Filho F.M., et al. Endoscopic ablation of Barrett's esophagus using argon plasma coagulation: a prospective study after fundoplication. Dis Esophagus 17 (2004) 243-246
68. Dulai G.S., Jensen D.M., Cortina G., et al. Randomized trial of argon plasma coagulation vs. multipolar electrocoagulation for ablation of Barrett's esophagus. Gastrointest Endosc 61 2 (2005) 232-240
69. Kelty C.J., Ackroyd R., Brown N.J., et al. Endoscopic ablation of Barrett's oesophagus: a randomized controlled trial of photodynamic therapy vs. argon plasma coagulation. Aliment Pharmacol Ther 20 11-12 (2004) 1289-1296
70. Hage M., Siersema P.D., van Dekken H., et al. 5-aminolevulinic acid photodynamic therapy versus argon plasma coagulation for ablation of Barrett's oesophagus: a randomised trial. Gut 53 6 (2004) 785-790
71. Pech O., Gossner L., May A., et al. Long-term results of photodynamic therapy with 5-aminolevulinic acid for superficial Barrett's cancer and high-grade intraepithelial neoplasia. Gastrointest Endosc 62 1 (2005) 24-30
72. Peters F., Kara M., Rosmolen W., et al. Poor results of 5-aminolevulinic acid-photodynamic therapy for residual high-grade dysplasia and early cancer in Barrett's esophagus after endoscopic resection. Endoscopy 37 5 (2005) 418-424
73. Ragunath K., Krasner N., Raman V.S., et al. Endoscopic ablation of dysplastic Barrett's oesophagus comparing argon plasma coagulation and photodynamic therapy: a randomized prospective trial assessing efficacy and cost-effectiveness. Scand J Gastroenterol 40 7 (2005) 750-758
74. Manner H., May A., Miehlke S., et al. Ablation of non-neoplastic Barrett's mucosa using argon plasma coagulation with concomitant esomeprazole therapy (APBANEX): a prospective multicenter evaluation. Am J Gastroenterol 101 8 (2006) 1762-1769
75. Fleischer D. Lasers and gastroenterology. Am J Gastroenterol 79 5 (1984) 406-415
76. Berenson M.M., Johnson T.D., Markowitz N.R., et al. Restoration of squamous mucosa after ablation of Barrett's esophageal epithelium. Gastroenterology 104 6 (1993) 1686-1691
77. Brandt L.J., and Kauvar D.R. Laser-induced transient regression of Barrett's epithelium. Gastrointest Endosc 38 5 (1992) 619-622
78. van den Boogert J., van Hillegersberg R., Siersema P.D., et al. Endoscopic ablation therapy for Barrett's esophagus with high-grade dysplasia: a review. Am J Gastroenterol 94 5 (1999) 1153-1160
79. Gossner L., May A., Stolte M., et al. KTP laser destruction of dysplasia and early cancer in columnar-lined Barrett's esophagus. Gastrointest Endosc 49 1 (1999) 8-12
80. Biddlestone L.R., Barham C.P., Wilkinson S.P., et al. The histopathology of treated Barrett's esophagus: squamous reepithelialization after acid suppression and laser and photodynamic therapy. Am J Surg Pathol 22 2 (1998) 239-245
81. Barham C.P., Jones R.L., Biddlestone L.R., et al. Photothermal laser ablation of Barrett's oesophagus: endoscopic and histological evidence of squamous re-epithelialisation. Gut 41 3 (1997) 281-284
82. Bonavina L., Via A., Incarbone R., et al. Results of surgical therapy in patients with Barrett's adenocarcinoma. World J Surg 27 9 (2003) 1062-1066
83. Bowers S.P., Mattar S.G., Waring P.J., et al. KTP laser ablation of Barrett's esophagus after antireflux surgery results in long-term loss of intestinal metaplasia. Potassium-titanyl-phosphate. Surg Endosc 17 1 (2003) 49-54
84. Fisher R.S., Bromer M.Q., Thomas R.M., et al. Predictors of recurrent specialized intestinal metaplasia after complete laser ablation. Am J Gastroenterol 98 9 (2003) 1945-1951
85. Luman W., Lessels A.M., and Palmer K.R. Failure of Nd-YAG photocoagulation therapy as treatment for Barrett's oesophagus-a pilot study. Eur J Gastroenterol Hepatol 8 7 (1996) 619-630
86. Norberto L., Polese L., Angriman I., et al. High-energy laser therapy of Barrett's esophagus: preliminary results. World J Surg 28 4 (2004) 350-354
87. Salo J.A., Salminen J.T., Kiviluoto T.A., et al. Treatment of Barrett's esophagus by endoscopic laser ablation and antireflux surgery. Ann Surg 227 1 (1998) 40-44
88. Weston A.P., and Sharma P. Neodymium:yttrium-aluminum garnet contact laser ablation of Barrett's high grade dysplasia and early adenocarcinoma. Am J Gastroenterol 97 12 (2002) 2998-3006
89. McCaughan Jr. J.S., Ellison E.C., Guy J.T., et al. Photodynamic therapy for esophageal malignancy: a prospective twelve-year study. Ann Thorac Surg 62 4 (1996) 1005-1009
90. Wang K. Photodynamic therapy made simple. Clinical Perspectives in Gastroenterology (2001) March/April, 90-100
91. Barr H., Krasner N., Boulos P.B., et al. Photodynamic therapy for colorectal cancer: a quantitative pilot study. Br J Surg 77 1 (1990) 93-96
92. Heier S.K., Rothman K.A., Heier L.M., et al. Photodynamic therapy for obstructing esophageal cancer: light dosimetry and randomized comparison with Nd:YAG laser therapy. Gastroenterology 109 1 (1995) 63-73
93. Webber J., Herman M., Kessel D., et al. Current concepts in gastrointestinal photodynamic therapy. Ann Surg 230 1 (1999) 12-23
94. Kubba A.K. Role of photodynamic therapy in the management of gastrointestinal cancer. Digestion 60 1 (1999) 1-10
95. Chen X., and Yang C.S. Esophageal adenocarcinoma: a review and perspectives on the mechanism of carcinogenesis and chemoprevention. Carcinogenesis 22 8 (2001) 1119-1129
96. Malhi-Chowla N., Wolfsen H.C., and DeVault K.R. Esophageal dysmotility in patients undergoing photodynamic therapy. Mayo Clin Proc 76 10 (2001) 987-989
97. Mang T.S. Laser and light sources for PDT. Photodiagnosis and Photodynamic Therapy 1 (2004) 43-48
98. Nijhawan P.K., Wolfsen H.C., Wang K.K., et al. Cutaneous photosensitivity after photodynamic therapy: is it really more common in sunny climates?. [abstract]. Gastroenterology 118 4 Suppl 2 (2000) A227
99. Overholt B.F., Panjehpour M., and Haydek J.M. Photodynamic therapy for Barrett's esophagus: follow-up in 100 patients. Gastrointest Endosc 49 1 (1999) 1-7
100. Panjehpour M., Overholt B.F., Haydek J.M., et al. Results of photodynamic therapy for ablation of dysplasia and early cancer in Barrett's esophagus and effect of oral steroids on stricture formation. Am J Gastroenterol 95 9 (2000) 2177-2184
101. Ukleja A., Scolapio J.S., and Wolfsen H.C. Endoscopic ultrasonography (EUS) and endoscopic mucosal resection (EMR) for staging and treatment of high-grade dysplasia (HGD) and early adenocarcinoma (EAC) in Barrett's esophagus (BE). [abstract]. Gastroenterology 116 (1999) A582
102. Wang K.K. Current status of photodynamic therapy of Barrett's esophagus. Gastrointest Endosc 49 3 Pt 2 (1999) S20-S23
103. Wang K.K., and Kim J.Y. Photodynamic therapy in Barrett's esophagus. Gastrointest Endosc Clin N Am 13 3 (2003) 483-489
104. Wang K.K., Wong Kee Song L.M., Buttar N.S., et al. Barrett's esophagus after photodynamic therapy: risk of cancer development during long-term follow-up. [abstract]. Gastroenterology 126 Suppl 2 (2004) A50
105. Wolfsen H.C. Present status of photodynamic therapy for high-grade dysplasia in Barrett's esophagus. J Clin Gastroenterol 39 3 (2005) 189-202
106. Wolfsen H.C. Photodynamic therapy for Barrett's esophagus with high-grade dysplasia. Compr Ther 31 2 (2005) 137-144
107. Wolfsen H.C., and Hemminger L.L. Photodynamic therapy for dysplastic Barrett's esophagus and mucosal adenocarcinoma. [abstract]. Gastrointest Endosc 59 5 (2004) AB251
108. Wolfsen H.C., and Ng C.S. Cutaneous consequences of photodynamic therapy. Cutis 69 2 (2002) 140-142
109. Wolfsen H.C., Woodward T.A., and Raimondo M. Photodynamic therapy for dysplastic Barrett's esophagus and early esophageal adenocarcinoma. Mayo Clin Proc 77 11 (2002) 1176
110. Javaid B., Watt P., and Krasner N. Photodynamic therapy (PDT) for oesophageal dysplasia and early carcinoma with mTHPC (m-tetrahydroxyphenyl chlorin): a preliminary study. Lasers Med Sci 1 1 (2002) 51-56
111. Lovat L.B., Jamieson N.F., Novelli M.R., et al. Photodynamic therapy with m-tetrahydroxyphenyl chlorin for high-grade dysplasia and early cancer in Barrett's columnar lined esophagus. Gastrointest Endosc 62 4 (2005) 617-623
112. Prosst R.L., Wolfsen H.C., and Gahlen J. Photodynamic therapy for esophageal diseases: a clinical update. Endoscopy 35 12 (2003) 1059-1068
113. Wolfsen H.C. Photodynamic therapy for mucosal esophageal adenocarcinoma and dysplastic Barrett's esophagus. Dig Dis 20 1 (2002) 5-17
114. Wolfsen H.C., Hemminger L.L., and DeVault K.R. Barrett's dysplasia and mucosal carcinoma patients referred for photodynamic therapy-do they come from surveillance programs?. [abstract]. Gastrointest Endosc 59 5 (2004) AB265
115. Hemminger L.L., and Wolfsen H.C. Photodynamic therapy for Barrett's esophagus and high-grade dysplasia: results of a patient satisfaction survey. Gastroenterol Nurs 25 4 (2002) 139-141
116. Hur C., Nishioka N.S., and Gazelle G.S. Cost-effectiveness of photodynamic therapy for treatment of Barrett's esophagus with high-grade dysplasia. Dig Dis Sci 48 7 (2003) 1273-1283
117. Wolfsen H.C., and Hemminger L.L. Salvage photodynamic therapy for persistent oesophageal cancer after chemoradiation therapy. Photodiagnosis and Photodynamic Therapy 3 1 (2006) 11-15
118. Wang K.K. Photodynamic therapy of Barrett's esophagus. Gastrointest Endosc Clin N Am 10 3 (2000) 409-419
119. Panjehpour M., Overholt B.F., Phan M.N., et al. Optimization of light dosimetry for photodynamic therapy of Barrett's esophagus: efficacy vs. incidence of stricture after treatment. Gastrointest Endosc 61 1 (2005) 13-18
120. Wolfsen H.C. Bare fiber photodynamic therapy using porfimer sodium for esophageal disease. Photodiagnosis and Photodynamic Therapy (2006) 87-92
121. Ackroyd R., Brown N.J., Stephenson T.J., et al. Ablation treatment for Barrett's oesophagus: what depth of tissue destruction is needed?. J Clin Pathol 52 7 (1999) 509-512
122. Ganz R.A., Utley D.S., Stern R.A., et al. Complete ablation of esophageal epithelium with a balloon-based bipolar electrode: a phased evaluation in the porcine and in the human esophagus. Gastrointest Endosc 60 6 (2004) 1002-1010
123. Dunkin B.J., Martinez J., Bejarano P.A., et al. Thin layer ablation of human esophageal epithelium using a bipolar radiofrequency balloon device (BARRx System). Surg Endosc 20 (2005) 125-130
124. Sharma V.K., Fleisher D.E., Wang K.K., et al. A randomized trial of radio-frequency ablation of specialized intestinal metaplasia of the esophagus. Gastrointest Endosc 59 (2004) AB113
125. Bergman J., Sondermeijer C., Peters F., et al. Circumferential balloon-based radiofrequency ablation for Barrett's esophagus in patients with low-grade dysplasia or high-grade dysplasia with and without prior endoscopic resection using the HALO-360 ablation system. Gastrointest Endosc 63 5 (2006) AB137
126. Ganz R., Overholt B., Panjehpour M., et al. Treatment of Barrett's esophagus and high-grade dysplasia using the HALO-360 ablation system: a multicenter experience. Gastrointest Endosc 63 5 (2006) AB124
127. Sharma V.K., Wang K.K., Overholt B.F., et al. Balloon-based circumferential, endoscopic radiofrequency ablation of Barrett's esophagus: 1-year follow-up of 100 patients. Gastrointest Endosc 65 2 (2007) 185-195
128. Tsai F., Vosoghi M., Khoshini R., et al. Preliminary results of BARRx ablation trial in patients with nondysplastic intestinal metaplasia versus low- or high-grade dysplasia. Gastrointest Endosc 63 5 (2006) AB142
129. Grana L., Ablin R.J., Goldman S., et al. Freezing of the esophagus: histological changes and immunological response. Int Surg 66 4 (1981) 295-301
130. Johnston M.H., Eastone J.A., Horwhat J.D., et al. Cryoablation of Barrett's esophagus: a pilot study. Gastrointest Endosc 62 6 (2005) 842-848
131. Wolfsen H.C., Hemminger L.L., Raimondo M., et al. Photodynamic therapy and endoscopic mucosal resection for Barrett's dysplasia and early esophageal adenocarcinoma. South Med J 97 9 (2004) 827-830
132. Soetikno R.M., Gotoda T., Nakanishi Y., et al. Endoscopic mucosal resection. Gastrointest Endosc 57 4 (2003) 567-579
133. Ell C., May A., Gossner L., et al. Endoscopic mucosal resection of early cancer and high-grade dysplasia in Barrett's esophagus. Gastroenterology 118 4 (2000) 670-677
134. Seewald S., Akaraviputh T., Seitz U., et al. Circumferential EMR and complete removal of Barrett's epithelium: a new approach to management of Barrett's esophagus containing high-grade intraepithelial neoplasia and intramucosal carcinoma. Gastrointest Endosc 57 7 (2003) 854-859
135. Schneider A.R., Kriener S., Hoepffner N., et al. Submucosal injection of autolgous blood before endoscopic resection-an option to NaCl and hyaluronate? Results of an ex vivo pilot study. Gastrointest Endosc 63 5 (2006) AB80
136. Conio M., Cameron A.J., Chak A., et al. Endoscopic treatment of high-grade dysplasia and early cancer in Barrett's oesophagus. Lancet Oncol 6 5 (2005) 311-321
137. Mino-Kenudson M., Brugge W.R., Puricelli W.P., et al. Management of superficial Barrett's epithelium-related neoplasms by endoscopic mucosal resection: clinicopathologic analysis of 27 cases. Am J Surg Pathol 29 5 (2005) 680-686
138. May A., Gossner L., Behrens A., et al. A prospective randomized trial of two different endoscopic resection techniques for early stage cancer of the esophagus. Gastrointest Endosc 58 2 (2003) 167-175
139. Rosch T., Sarbia M., Schumacher B., et al. Attempted endoscopic en bloc resection of mucosal and submucosal tumors using insulated-tip knives: a pilot series. Endoscopy 36 9 (2004) 788-801
140. May A., Gossner L., Pech O., et al. Local endoscopic therapy for intraepithelial high-grade neoplasia and early adenocarcinoma in Barrett's oesophagus: acute-phase and intermediate results of a new treatment approach. Eur J Gastroenterol Hepatol 14 10 (2002) 1085-1091
141. Giovannini M., Bories E., Pesenti C., et al. Circumferential endoscopic mucosal resection in Barrett's esophagus with high-grade intraepithelial neoplasia or mucosal cancer. Preliminary results in 21 patients. Endoscopy 36 9 (2004) 782-787
142. Buttar N.S., Wang K.K., Lutzke L.S., et al. Combined endoscopic mucosal resection and photodynamic therapy for esophageal neoplasia within Barrett's esophagus. Gastrointest Endosc 54 6 (2001) 682-688
143. Nijhawan P.K., and Wang K.K. Endoscopic mucosal resection for lesions with endoscopic features suggestive of malignancy and high-grade dysplasia within Barrett's esophagus. Gastrointest Endosc Clin N Am 10 3 (2000) 421-437
144. Noguchi H., Naomoto Y., Kondo H., et al. Evaluation of endoscopic mucosal resection for superficial esophageal carcinoma. Surg Laparosc Endosc Percutan Tech 10 6 (2000) 343-350
145. Takeshita K., Tani M., Inoue H., et al. Endoscopic treatment of early oesophageal or gastric cancer. Gut 40 1 (1997) 123-127
146. Fedi P., Abrams J.A., Vakiani E., et al. Endoscopic mucosal resection (E
147. Peters F., Brakendhoff L.P., Curvers W.L., et al. Endoscopic resection in esophagus and stomach is safe: a prospective analysis of 303 procedures. Gastrointest Endosc 63 5 (2006) AB97
148. Rajan E., Gostout C.J., Feitoza A.B., et al. Widespread EMR: a new technique for removal of large areas of mucosa. Gastrointest Endosc 60 4 (2004) 623-627
149. Ross A., Larghi A., Stearns L., et al. Complete Barrett's eradication endoscopic mucosal resection as a treatment for high-grade dysplasia or intramucosal adenocarcinoma arising from Barrett's epithelium: a viable alternative to esophagectomy. Gastrointest Endosc 63 5 (2006) AB126